Current recommendations for prevention and therapy of extravasation reactions in dermato-oncology.
Despite the introduction of many targeted therapies, a wide variety of cytostatic agents are still frequently used in dermato-oncology. In order to avoid further morbidity in tumor patients, prevention of extravasation reactions is of highest importance. The optimal management of extravasation requires an early diagnosis, the application of specific antidotes and a well-trained oncology team.
Kähler
Katharina C
KC
Department of Dermatology and Venereology, UKSH, Kiel, Germany. kckaehler@yahoo.de
Mustroph
Dieter
D
Hauschild
Axel
A
D054697:Cytostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003880:Dermatology / Q000592:standards* / Q000639:trends; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000209:etiology / Q000451:nursing* / Q000517:prevention & control*; D005858:Germany; D006801:Humans; D008495:Medical Oncology / Q000592:standards* / Q000639:trends; D017410:Practice Guidelines as Topic; D012878:Skin Neoplasms / Q000188:drug therapy*
D054697:Cytostatic Agents; D003879:Dermatologic Agents